Grace Therapeutics (GRCE) Shares Outstanding (Entity) (2017 - 2026)

Grace Therapeutics (GRCE) Shares Outstanding (Entity) (2017 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Outstanding (Entity.) (Qtr)
1	Vertex Pharmaceuticals	139.40 Bn	131.55 Bn	2.84 Bn	253.35 Mn
2	Regeneron Pharmaceuticals	86.53 Bn	78.54 Bn	3.93 Bn	102.80 Mn
3	Argenx Se	65.20 Bn	60.02 Bn	1.37 Bn	62.54 Mn
4	Moderna	60.40 Bn	55.26 Bn	52.00 Mn	399.00 Mn
5	BeOne Medicines	42.17 Bn	37.07 Bn	1.53 Bn	113.02 Mn
6	Alnylam Pharmaceuticals	31.36 Bn	28.05 Bn	992.69 Mn	133.73 Mn
7	BioNTech SE	28.74 Bn	10.34 Bn	668.28 Mn	252.88 Mn
8	Insmed	27.45 Bn	26.29 Bn	358.27 Mn	218.28 Mn
9	Royalty Pharma	27.17 Bn	26.33 Bn	-	575.47 Mn
10	Grace Therapeutics	37.82 Mn	37.82 Mn	-	16.27 Mn

Download Data